US Stock MarketDetailed Quotes

BioXcel Therapeutics (BTAI)

Watchlist
  • 1.140
  • +0.030+2.70%
Close Jun 12 16:00 ET
  • 1.165
  • +0.025+2.23%
Post 20:01 ET
35.20MMarket Cap-0.24P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioXcel Therapeutics (BTAI) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
1.94%-11.81M
20.01%-57.62M
4.04%-14.21M
-14.99%-18.79M
45.74%-12.58M
31.98%-12.04M
53.53%-72.03M
44.87%-14.81M
56.53%-16.34M
39.34%-23.17M
Net income from continuing operations
-74.95%-12.69M
-17.28%-69.9M
-15.53%-12.55M
-126.45%-30.91M
-131.20%-19.19M
72.92%-7.25M
66.71%-59.6M
51.21%-10.86M
72.96%-13.65M
84.49%-8.3M
Operating gains losses
76.84%-1.52M
117.37%3.51M
44.96%-1.81M
360.29%12.54M
94.49%-663K
-21,763.33%-6.56M
-4,528.44%-20.18M
-2,601.64%-3.3M
-481,900.00%-4.82M
-2,104.40%-12.04M
Depreciation and amortization
-23.68%58K
-2.91%300K
-3.90%74K
-2.60%75K
-2.60%75K
-2.56%76K
-2.83%309K
-1.28%77K
-2.53%77K
-4.94%77K
Other non cash items
-81.98%558K
1.31%7.41M
-81.71%553K
-65.39%523K
123.69%3.24M
132.16%3.1M
107.08%7.32M
191.23%3.02M
75.49%1.51M
73.83%1.45M
Change In working capital
185.28%1.35M
71.77%-1.7M
73.90%-928K
-20.63%-1.6M
144.36%2.41M
-137.07%-1.58M
-398.76%-6.03M
61.36%-3.56M
-116.65%-1.32M
-161.48%-5.42M
-Change in receivables
-87.02%17K
-70.00%-102K
-82.03%-233K
-97.90%17K
96.08%-17K
142.67%131K
-133.90%-60K
-119.28%-128K
366.12%809K
-193.24%-434K
-Change in inventory
500.00%222K
-103.28%-43K
-131.09%-263K
-95.93%47K
156.43%136K
108.26%37K
21,966.67%1.31M
3,033.33%846K
1,341.94%1.16M
-992.59%-241K
-Change in prepaid assets
-270.89%-1.04M
-335.68%-8.16M
-876.49%-8.35M
67.10%-480K
114.16%65K
-32.52%608K
-164.82%-1.87M
-173.45%-855K
-164.82%-1.46M
-131.03%-459K
-Change in payables and accrued expense
197.62%2.22M
237.72%6.97M
340.60%8.01M
37.70%-1.08M
155.10%2.31M
-153.93%-2.27M
-601.25%-5.06M
69.65%-3.33M
-128.18%-1.74M
-155.72%-4.2M
-Change in other current liabilities
27.78%-65K
-8.09%-374K
-7.95%-95K
-9.09%-96K
-6.90%-93K
-8.43%-90K
-8.46%-346K
-7.32%-88K
-8.64%-88K
-10.13%-87K
Cash from discontinued investing activities
Operating cash flow
1.94%-11.81M
20.01%-57.62M
4.04%-14.21M
-14.99%-18.79M
45.74%-12.58M
31.98%-12.04M
53.53%-72.03M
44.87%-14.81M
56.53%-16.34M
39.34%-23.17M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
0
0
0
0
0
Net PPE purchase and sale
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-98.24%232K
54.17%56.52M
32.06%5.65M
8,166.96%37.53M
-97.42%137K
-50.42%13.2M
38.22%36.66M
101.41%4.28M
454K
2,021.60%5.3M
Net issuance payments of debt
---8.11M
--0
----
----
----
--0
---2.5M
----
----
----
Net common stock issuance
-39.33%8.5M
46.50%58.14M
-17.70%5.76M
8,069.66%38.23M
-97.44%140K
-47.63%14.01M
46.82%39.69M
194.78%7M
--468K
--5.48M
Proceeds from stock option exercised by employees
----
----
----
----
----
----
--0
--0
--0
--0
Net other financing activities
80.35%-158K
-207.58%-1.62M
48.89%-115K
-4,914.29%-702K
98.26%-3K
-587.18%-804K
48.13%-528K
10.71%-225K
---14K
---172K
Cash from discontinued financing activities
Financing cash flow
-98.24%232K
54.17%56.52M
32.06%5.65M
8,166.96%37.53M
-97.42%137K
-50.42%13.2M
38.22%36.66M
101.41%4.28M
--454K
2,021.60%5.3M
Net cash flow
Beginning cash position
-3.67%28.76M
-54.23%29.85M
-7.59%37.32M
-66.99%18.58M
-58.17%31.01M
-54.23%29.85M
-66.33%65.22M
-55.11%40.39M
-55.88%56.27M
-55.21%74.14M
Current changes in cash
-1,098.88%-11.58M
96.90%-1.1M
18.70%-8.56M
218.01%18.75M
30.40%-12.44M
-87.01%1.16M
72.48%-35.37M
57.43%-10.53M
57.74%-15.88M
52.94%-17.87M
End cash Position
-44.60%17.18M
-3.67%28.76M
-3.67%28.76M
-7.59%37.32M
-66.99%18.58M
-58.17%31.01M
-54.23%29.85M
-54.23%29.85M
-55.11%40.39M
-55.88%56.27M
Free cash flow
1.94%-11.81M
20.01%-57.62M
4.04%-14.21M
-14.99%-18.79M
45.74%-12.58M
31.98%-12.04M
53.54%-72.03M
44.87%-14.81M
56.53%-16.34M
39.38%-23.17M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 1.94%-11.81M20.01%-57.62M4.04%-14.21M-14.99%-18.79M45.74%-12.58M31.98%-12.04M53.53%-72.03M44.87%-14.81M56.53%-16.34M39.34%-23.17M
Net income from continuing operations -74.95%-12.69M-17.28%-69.9M-15.53%-12.55M-126.45%-30.91M-131.20%-19.19M72.92%-7.25M66.71%-59.6M51.21%-10.86M72.96%-13.65M84.49%-8.3M
Operating gains losses 76.84%-1.52M117.37%3.51M44.96%-1.81M360.29%12.54M94.49%-663K-21,763.33%-6.56M-4,528.44%-20.18M-2,601.64%-3.3M-481,900.00%-4.82M-2,104.40%-12.04M
Depreciation and amortization -23.68%58K-2.91%300K-3.90%74K-2.60%75K-2.60%75K-2.56%76K-2.83%309K-1.28%77K-2.53%77K-4.94%77K
Other non cash items -81.98%558K1.31%7.41M-81.71%553K-65.39%523K123.69%3.24M132.16%3.1M107.08%7.32M191.23%3.02M75.49%1.51M73.83%1.45M
Change In working capital 185.28%1.35M71.77%-1.7M73.90%-928K-20.63%-1.6M144.36%2.41M-137.07%-1.58M-398.76%-6.03M61.36%-3.56M-116.65%-1.32M-161.48%-5.42M
-Change in receivables -87.02%17K-70.00%-102K-82.03%-233K-97.90%17K96.08%-17K142.67%131K-133.90%-60K-119.28%-128K366.12%809K-193.24%-434K
-Change in inventory 500.00%222K-103.28%-43K-131.09%-263K-95.93%47K156.43%136K108.26%37K21,966.67%1.31M3,033.33%846K1,341.94%1.16M-992.59%-241K
-Change in prepaid assets -270.89%-1.04M-335.68%-8.16M-876.49%-8.35M67.10%-480K114.16%65K-32.52%608K-164.82%-1.87M-173.45%-855K-164.82%-1.46M-131.03%-459K
-Change in payables and accrued expense 197.62%2.22M237.72%6.97M340.60%8.01M37.70%-1.08M155.10%2.31M-153.93%-2.27M-601.25%-5.06M69.65%-3.33M-128.18%-1.74M-155.72%-4.2M
-Change in other current liabilities 27.78%-65K-8.09%-374K-7.95%-95K-9.09%-96K-6.90%-93K-8.43%-90K-8.46%-346K-7.32%-88K-8.64%-88K-10.13%-87K
Cash from discontinued investing activities
Operating cash flow 1.94%-11.81M20.01%-57.62M4.04%-14.21M-14.99%-18.79M45.74%-12.58M31.98%-12.04M53.53%-72.03M44.87%-14.81M56.53%-16.34M39.34%-23.17M
Investing cash flow
Cash flow from continuing investing activities 0000000000
Net PPE purchase and sale --0--0--0--0--0--0--0--0--0--0
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities -98.24%232K54.17%56.52M32.06%5.65M8,166.96%37.53M-97.42%137K-50.42%13.2M38.22%36.66M101.41%4.28M454K2,021.60%5.3M
Net issuance payments of debt ---8.11M--0--------------0---2.5M------------
Net common stock issuance -39.33%8.5M46.50%58.14M-17.70%5.76M8,069.66%38.23M-97.44%140K-47.63%14.01M46.82%39.69M194.78%7M--468K--5.48M
Proceeds from stock option exercised by employees --------------------------0--0--0--0
Net other financing activities 80.35%-158K-207.58%-1.62M48.89%-115K-4,914.29%-702K98.26%-3K-587.18%-804K48.13%-528K10.71%-225K---14K---172K
Cash from discontinued financing activities
Financing cash flow -98.24%232K54.17%56.52M32.06%5.65M8,166.96%37.53M-97.42%137K-50.42%13.2M38.22%36.66M101.41%4.28M--454K2,021.60%5.3M
Net cash flow
Beginning cash position -3.67%28.76M-54.23%29.85M-7.59%37.32M-66.99%18.58M-58.17%31.01M-54.23%29.85M-66.33%65.22M-55.11%40.39M-55.88%56.27M-55.21%74.14M
Current changes in cash -1,098.88%-11.58M96.90%-1.1M18.70%-8.56M218.01%18.75M30.40%-12.44M-87.01%1.16M72.48%-35.37M57.43%-10.53M57.74%-15.88M52.94%-17.87M
End cash Position -44.60%17.18M-3.67%28.76M-3.67%28.76M-7.59%37.32M-66.99%18.58M-58.17%31.01M-54.23%29.85M-54.23%29.85M-55.11%40.39M-55.88%56.27M
Free cash flow 1.94%-11.81M20.01%-57.62M4.04%-14.21M-14.99%-18.79M45.74%-12.58M31.98%-12.04M53.54%-72.03M44.87%-14.81M56.53%-16.34M39.38%-23.17M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +11.05%
Sample Name
Sample Code
 +1.03%
Sample Name
Sample Code
 -2.29%
4
VanEck Oil Services ETF
OIH
-3.00%
5
ProShares Ultra Energy
DIG
-3.15%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.02%
Sample Name
Sample Code
 +9.96%
Sample Name
Sample Code
 +9.80%
4
Qifu Technology
QFIN
+5.99%
5
Futu Holdings Ltd
FUTU
+5.64%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran peace talks have entered a critical window! On the 14th, Iranian sources indicated that Pakistan will host a video conference Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -